Anika Therapeutics ANIK Tax on Share Settlement
Tax on Share Settlement at other companies
Other financials
Where this comes from
Reported directly by Anika Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation.
The official record: Anika Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Anika Therapeutics's tax on share settlement.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Anika Therapeutics's tax on share settlement?
- Anika Therapeutics (ANIK) reported tax on share settlement of $1.66M in Q1 2026.
- How has Anika Therapeutics's tax on share settlement changed year-over-year?
- Anika Therapeutics's tax on share settlement increased by 13.0% year-over-year, from $1.47M to $1.66M.
- What is the long-term trend for Anika Therapeutics's tax on share settlement?
- Over 4 years (2021 to 2025), Anika Therapeutics's tax on share settlement has grown at a 34.0% compound annual growth rate (CAGR), from $486K to $1.57M.
- What does tax on share settlement mean?
- Cash paid to tax authorities for employee share vesting, where the company withholds shares and pays the tax obligation in cash.